Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: J Allergy Clin Immunol. 2013 Dec 25;133(3):872–879.e7. doi: 10.1016/j.jaci.2013.10.054

Figure 5.

Figure 5

A, Ex vivo frequencies of each DR04:01-restricted TGP-specific CD4+ T cells in allergic subjects and in ASIT-treated patients. b, Contribution of each DR04:01-restricted TGP epitope to the global allergen-specific CD4+ T cell response in SIT-treated individuals. C, Overall frequencies of CD27 and CD27+ DR04:01-restricted TGP allergen-specific T cells in allergic subjects (n=10), non-atopic individuals (n=5) and patients post-ASIT (n=6).